Both in Biotechnology
Agenus vs X4 Pharmaceuticals
Over the past year AGEN returned +68.0% and XFOR returned −22.5%; their daily moves had a correlation of 0.13.
AGEN +68.0% XFOR −22.5%Growth of $1, one year, split-adjusted
| Metric | AGEN | XFOR |
|---|---|---|
| Price | $6.67 | $3.17 |
| Market cap | $301.2M | $314.3M |
| Today | +2.14% | −5.37% |
| 1 month | −23.6% | +9.3% |
| 6 months | +60.0% | −24.5% |
| Year to date | +112.4% | −20.8% |
| 1 year | +68.0% | −21.5% |
| Revenue growth (YoY) | +34.4% | +346.3% |
| Gross margin | 100.0% | 81.6% |
| Net margin | −1.7% | −183.5% |
| P/E (TTM) | 3.3× | — |
| Price / sales | 2.3× | 19.8× |
| Net cash | -$11.3M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 88.6% | 60.7% |
| Short % of float | 16.6% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).